Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Biol Open ; 6(10): 1528-1540, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28870996

ABSTRACT

Drosophila Vestigial is the founding member of a protein family containing a highly conserved domain, called Tondu, which mediates their interaction with members of the TEAD family of transcription factors (Scalloped in Drosophila). In Drosophila, the Vestigial/Scalloped complex controls wing development by regulating the expression of target genes through binding to MCAT sequences. In vertebrates, there are four Vestigial-like genes, the functions of which are still not well understood. Here, we describe the regulation and function of vestigial-like 3 (vgll3) during Xenopus early development. A combination of signals, including FGF8, Wnt8a, Hoxa2, Hoxb2 and retinoic acid, limits vgll3 expression to hindbrain rhombomere 2. We show that vgll3 regulates trigeminal placode and nerve formation and is required for normal neural crest development by affecting their migration and adhesion properties. At the molecular level, vgll3 is a potent activator of pax3, zic1, Wnt and FGF, which are important for brain patterning and neural crest cell formation. Vgll3 interacts in the embryo with Tead proteins but unexpectedly with Ets1, with which it is able to stimulate a MCAT driven luciferase reporter gene. Our findings highlight a critical function for vgll3 in vertebrate early development.

2.
Dev Genes Evol ; 226(4): 297-315, 2016 07.
Article in English | MEDLINE | ID: mdl-27116603

ABSTRACT

The members of the vestigial-like gene family have been identified as homologs of the Drosophila vestigial, which is essential to wing formation. All members of the family are characterized by the presence of the TONDU domain, a highly conserved sequence that mediates their interaction with the transcription factors of the TEAD family. Mammals possess four vestigial-like genes that can be subdivided into two classes, depending on the number of Tondu domains present. While vestigial proteins have been studied in great depth in Drosophila, we still have sketchy knowledge of the functions of vestigial-like proteins in vertebrates. Recent studies have unveiled unexpected functions for some of these members and reveal the role they play in the Hippo pathway. Here, we present the current knowledge about vestigial-like family gene members and their functions, together with their identification in different taxa.


Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Evolution, Molecular , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Animals , Carrier Proteins , Co-Repressor Proteins/genetics , DNA-Binding Proteins/chemistry , Drosophila Proteins/genetics , Drosophila melanogaster , Gene Expression , Gene Expression Regulation , Humans , Muscle Proteins/genetics , Nuclear Proteins/chemistry , Protein Domains , Transcription Factors/genetics
3.
Development ; 140(16): 3311-22, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23863483

ABSTRACT

Pluripotent mouse embryonic stem cells (mESCs), maintained in the presence of the leukemia inhibitory factor (LIF) cytokine, provide a powerful model with which to study pluripotency and differentiation programs. Extensive microarray studies on cultured cells have led to the identification of three LIF signatures. Here we focus on muscle ras oncogene homolog (MRAS), which is a small GTPase of the Ras family encoded within the Pluri gene cluster. To characterise the effects of Mras on cell pluripotency and differentiation, we used gain- and loss-of-function strategies in mESCs and in the Xenopus laevis embryo, in which Mras gene structure and protein sequence are conserved. We show that persistent knockdown of Mras in mESCs reduces expression of specific master genes and that MRAS plays a crucial role in the downregulation of OCT4 and NANOG protein levels upon differentiation. In Xenopus, we demonstrate the potential of Mras to modulate cell fate at early steps of development and during neurogenesis. Overexpression of Mras allows gastrula cells to retain responsiveness to fibroblast growth factor (FGF) and activin. Collectively, these results highlight novel conserved and pleiotropic effects of MRAS in stem cells and early steps of development.


Subject(s)
Embryonic Stem Cells/enzymology , Gene Expression Regulation, Developmental , Monomeric GTP-Binding Proteins/metabolism , Xenopus laevis/embryology , Activins/pharmacology , Amino Acid Sequence , Animals , Biomarkers/metabolism , Brain/embryology , Brain/enzymology , Conserved Sequence , Embryonic Induction , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/metabolism , Female , Fibroblast Growth Factors/pharmacology , Gastrula/cytology , Gastrula/drug effects , Gastrula/enzymology , Gene Knockdown Techniques , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Leukemia Inhibitory Factor/pharmacology , Mice , Molecular Sequence Data , Monomeric GTP-Binding Proteins/genetics , Nanog Homeobox Protein , Neurogenesis , Octamer Transcription Factor-3/genetics , Octamer Transcription Factor-3/metabolism , Ovary/enzymology , Xenopus laevis/genetics , Xenopus laevis/metabolism , ras Proteins
4.
PLoS One ; 8(1): e54550, 2013.
Article in English | MEDLINE | ID: mdl-23342169

ABSTRACT

ZFP36 constitutes a small family of RNA binding proteins (formerly known as the TIS11 family) that target mRNA and promote their degradation. In mammals, ZFP36 proteins are encoded by four genes and, although they show similar activities in a cellular RNA destabilization assay, there is still a limited knowledge of their mRNA targets and it is not known whether or not they have redundant functions. In the present work, we have used the Xenopus embryo, a model system allowing gain- and loss-of-function studies, to investigate, whether individual ZFP36 proteins had distinct or redundant functions. We show that overexpression of individual amphibian zfp36 proteins leads to embryos having the same defects, with alteration in somites segmentation and pronephros formation. In these embryos, members of the Notch signalling pathway such as hairy2a or esr5 mRNA are down-regulated, suggesting common targets for the different proteins. We also show that mouse Zfp36 protein overexpression gives the same phenotype, indicating an evolutionary conserved property among ZFP36 vertebrate proteins. Morpholino oligonucleotide-induced loss-of-function leads to defects in pronephros formation, reduction in tubule size and duct coiling alterations for both zfp36 and zfp36l1, indicating no functional redundancy between these two genes. Given the conservation in gene structure and function between the amphibian and mammalian proteins and the conserved mechanisms for pronephros development, our study highlights a potential and hitherto unreported role of ZFP36 gene in kidney morphogenesis.


Subject(s)
Xenopus Proteins/metabolism , Animals , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental/genetics , Gene Expression Regulation, Developmental/physiology , Xenopus , Xenopus Proteins/genetics
5.
Int J Dev Biol ; 54(8-9): 1375-82, 2010.
Article in English | MEDLINE | ID: mdl-20712000

ABSTRACT

The Drosophila Vestigial and Scalloped proteins form heterodimers that control wing development and are involved in muscle differentiation. Four vestigial like genes have been described in mammals. Similar to the Drosophila vestigial gene, they encode a short conserved domain (TONDU) required for interaction with the mammalian paralogues of Drosophila Scalloped (i.e., TEAD proteins). We previously identified two TEAD genes in Xenopus laevis and we report here the expression of four distinct vestigial like genes in Xenopus (vgll1-4) that represent amphibian orthologs of the mammalian vestigial like genes. Vgll1 has a unique expression pattern which is restricted to epidermal cells, both in the embryo and in the adult. Vgll2 is expressed in the skeletal muscle lineage downstream of myogenic factors and in the embryonic brain similar to the avian and mammalian orthologues. Vgll3 expression is transient, identifies embryonic hindbrain rhombomere 2, and is negatively regulated by en2, but not by egr2. Vgll4 is mainly expressed in anterior neural structures. In summary, the four Xenopus vgll genes have unique/complex expression profiles and they are differently expressed during embryogenesis. Moreover, these amphibian vestigial like genes display distinct responses to the major signaling pathways (i.e., activin, FGF or BMP) that orchestrate pattern-formation during early development.


Subject(s)
Gene Expression Profiling , Multigene Family , Xenopus Proteins/genetics , Xenopus/genetics , Activins/pharmacology , Amino Acid Sequence , Animals , Dose-Response Relationship, Drug , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/embryology , Embryo, Nonmammalian/metabolism , Fibroblast Growth Factor 2/pharmacology , Gene Expression Regulation, Developmental/drug effects , Genetic Variation , In Situ Hybridization , Molecular Sequence Data , Phylogeny , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Species Specificity , Transcription Factors/genetics , Vertebrates/classification , Vertebrates/genetics , Xenopus/classification , Xenopus/embryology , Xenopus Proteins/classification , Xenopus laevis/embryology , Xenopus laevis/genetics
6.
Cell Biol Int ; 33(6): 621-31, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19248835

ABSTRACT

Stromal cells follow a vascular smooth muscle differentiation pathway. However, cell culture models performed from human bone marrow do not allow the obtention of a large proportion of highly differentiated smooth muscle cells (SMC) and their differentiation pathways remain unclear. We have characterized a new model of SMC differentiation from human bone marrow stromal cells by using different factors (bFGF, EGF, insulin and BMP-4). A relative homogeneous population of differentiated SMC was reproducibly obtained in short-term culture with high expression of SMC markers. Id gene expression was investigated and showed that (1) Id2 mRNA expression was upregulated during SMC differentiation without change of Id1 mRNA and (2) Id1 gene expression highly increased concomitantly with a decrease of SMC markers while Id2 mRNA was slightly modulated. Our data suggested that Id genes are potentially implicated in the differentiation pathway of human SMC from bone marrow.


Subject(s)
Bone Marrow Cells/cytology , Inhibitor of Differentiation Protein 1/metabolism , Inhibitor of Differentiation Protein 2/metabolism , Myocytes, Smooth Muscle/metabolism , Adult , Aged , Bone Marrow Cells/metabolism , Bone Morphogenetic Protein 4/metabolism , Cell Differentiation , Cell Proliferation , Cells, Cultured , Gene Expression Regulation , Humans , Immunophenotyping , Inhibitor of Differentiation Protein 1/genetics , Inhibitor of Differentiation Protein 2/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Middle Aged , Myocytes, Smooth Muscle/cytology , RNA, Messenger/metabolism , Stromal Cells/cytology
7.
Dev Dyn ; 237(11): 3373-86, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18855898

ABSTRACT

By comparison with skeletal or cardiac developmental programs, little is known regarding the specific factors that promote specification and differentiation of smooth muscle cells from pluripotent cells. We have analyzed the developmental expression of a subset of smooth muscle genes during Xenopus early development and showed that similar to mammals and avians, Xenopus smooth muscle myosin heavy chain (SM-MHC) is a highly specific marker of smooth muscle differentiation. Embryonic cells from animal pole explants of Xenopus blastula can be induced by basic fibroblast growth factor, Wnt, and bone morphogenetic protein signals to adopt the smooth muscle pathway. Explants from early embryos that contain neural crest cells can also differentiate into cells expressing smooth muscle genes. We examined the interplay of several transcription factors, that is SRF, myocardin, and GATA6, that induce the expression of SM-MHC in animal cap cells and found that myocardin-dependent expression of smooth muscle genes in animal cap cells is synergized by SRF but is strongly antagonized by GATA6.


Subject(s)
Blastula/embryology , Gene Expression Regulation, Developmental/physiology , Muscle, Smooth/metabolism , Myosin Heavy Chains/biosynthesis , Transcription Factors/metabolism , Animals , Blastula/cytology , Bone Morphogenetic Proteins/metabolism , Fibroblast Growth Factor 2/metabolism , Muscle, Smooth/cytology , Wnt Proteins/metabolism , Xenopus laevis
8.
Int J Dev Biol ; 51(8): 745-52, 2007.
Article in English | MEDLINE | ID: mdl-17939122

ABSTRACT

Transcription enhancer factors 1 (TEF-1 or TEAD) make a highly conserved family of eukaryotic DNA binding proteins that activate not only viral regulatory elements but muscle specific genes and are involved in several developmental processes. In this study, we report the identification and the expression pattern of NTEF-1 (TEAD1) and DTEF-1 (TEAD3), two members of this family in Xenopus laevis. Both X. laevis NTEF-1 (XNTEF-1 or XTEAD1) and DTEF-1 (XDTEF-1 or XTEAD3) possess a 72 amino acid TEA domain characteristic of TEF-1 proteins. XNTEF-1 is a 426 amino acid protein that has 96% identity with the avian or the mammalian NTEF-1 proteins while XDTEF-1 is a 433 amino acid protein with 77 to 80% identity with the avian and mammalian DTEF-1 sequences respectively. Temporal expression analysis by RT-PCR indicated that the two genes are expressed maternally and throughout embryonic development. In the adult, the two genes are broadly expressed although they showed differences of expression between tissues. Spatial expression analysis by whole mount in situ hybridization showed that the XNTEF-1 and XDTEF-1 mRNAS were predominantly detected in eye, embryonic brain, somites and heart. In animal cap assay, the two genes are activated by bFGF but are differently regulated by BMP4, and the muscle regulatory factor Mef2d.


Subject(s)
DNA-Binding Proteins/metabolism , Gene Expression Regulation, Developmental , Transcription Factors/metabolism , Xenopus laevis/metabolism , Amino Acid Sequence , Animals , DNA, Complementary/metabolism , Embryonic Development , Humans , In Situ Hybridization , Mice , Molecular Sequence Data , MyoD Protein/metabolism , Protein Structure, Tertiary , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , TEA Domain Transcription Factors , Time Factors
9.
J Biol Chem ; 281(45): 34406-20, 2006 Nov 10.
Article in English | MEDLINE | ID: mdl-16959782

ABSTRACT

In vertebrates, the actin-binding proteins tropomyosins are encoded by four distinct genes that are expressed in a complex pattern during development and muscle differentiation. In this study, we have characterized the transcriptional machinery of the alpha-tropomyosin (alpha-Tm) gene in muscle cells. Promoter analysis revealed that a 284-bp proximal promoter region of the Xenopus laevis alpha-Tm gene is sufficient for maximal activity in the three muscle cell types. The transcriptional activity of this promoter in the three muscle cell types depends on both distinct and common cis-regulatory sequences. We have identified a 30-bp conserved sequence unique to all vertebrate alpha-Tm genes that contains an MCAT site that is critical for expression of the gene in all muscle cell types. This site can bind transcription enhancer factor-1 (TEF-1) present in muscle cells both in vitro and in vivo. In serum-deprived differentiated smooth muscle cells, TEF-1 was redistributed to the nucleus, and this correlated with increased activity of the alpha-Tm promoter. Overexpression of TEF-1 mRNA in Xenopus embryonic cells led to activation of both the endogenous alpha-Tm gene and the exogenous 284-bp promoter. Finally, we show that, in transgenic embryos and juveniles, an intact MCAT sequence is required for correct temporal and spatial expression of the 284-bp gene promoter. This study represents the first analysis of the transcriptional regulation of the alpha-Tm gene in vivo and highlights a common TEF-1-dependent regulatory mechanism necessary for expression of the gene in the three muscle lineages.


Subject(s)
Enhancer Elements, Genetic/physiology , Gene Expression Regulation, Developmental/genetics , Muscles/embryology , Transcription Factors/metabolism , Tropomyosin/genetics , Animals , Base Sequence , Blotting, Western , Cell Nucleus , Cells, Cultured , Chickens , Chromatin Immunoprecipitation , DNA-Binding Proteins , Electrophoretic Mobility Shift Assay , Fluorescent Antibody Technique , Molecular Sequence Data , Muscle Cells/metabolism , Muscles/metabolism , Mutagenesis, Site-Directed , Myocytes, Cardiac , Plasmids , Promoter Regions, Genetic/genetics , Protein Biosynthesis , Rabbits , Rats , TEA Domain Transcription Factors , Transcription, Genetic , Transfection , Tropomyosin/metabolism , Xenopus laevis/embryology , Xenopus laevis/metabolism
10.
Microsc Res Tech ; 69(8): 606-12, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16718652

ABSTRACT

The increased generation and up-regulated activity of bone resorbing cells (osteoclasts) play a part in the impairment of bone remodeling in many bone diseases. Numerous drugs (bisphosphonates, calcitonin, selective estrogen receptor modulators) have been proposed to inhibit this increased osteoclastic activity. In this report, we describe a pit resorption assay quantified by scanning electron microscopy coupled with image analysis. Total rabbit bone cells with large numbers of osteoclasts were cultured on dentin slices. The whole surface of the dentin slice was scanned and both the number of resorption pits and the total resorbed surface area were measured. Resorption pits appeared at 48 h and increased gradually up to 96 h. Despite the observation of a strong correlation between the total resorption area and the number of pits, we suggest that area measurement is the most relevant marker for osteoclastic activity. Osteotropic factors stimulating or inhibiting osteoclastic activity were used to test the variations in resorption activity as measured with our method. This reproducible and sensitive quantitative method is a valuable tool for screening for osteoclastic inhibitors and, more generally, for investigating bone modulators.


Subject(s)
Image Processing, Computer-Assisted/methods , Microscopy, Electron, Scanning/methods , Osteoclasts/cytology , Animals , Bone Density Conservation Agents/pharmacology , Bone Resorption/metabolism , Bone Resorption/prevention & control , Carrier Proteins/pharmacology , Cells, Cultured , Diphosphonates/pharmacology , Imidazoles/pharmacology , Membrane Glycoproteins/pharmacology , Microscopy, Fluorescence , Osteoclasts/drug effects , Osteoclasts/ultrastructure , RANK Ligand , Rabbits , Time Factors , Zoledronic Acid
11.
Biomaterials ; 26(14): 2073-80, 2005 May.
Article in English | MEDLINE | ID: mdl-15576181

ABSTRACT

One type of gem-bisphosphonate (Zoledronate) has been chemically associated onto calcium phosphate (CaP) compounds of various compositions. For that purpose, CaP powders of controlled granulometry have been suspended in aqueous Zoledronate solutions of variable concentrations. Using mainly (31)P NMR spectroscopy, two different association modes have been observed, according to the nature of the CaP support and/or the initial concentration of the Zoledronate solution. beta-tricalcium phosphate (beta-TCP) and mixtures of hydroxyapatite and beta-TCP (BCPs) appear to promote Zoledronate-containing crystals formation. On the other hand, at concentrations <0.05 mol l(-1) CDAs (calcium deficients apatites) seem to undergo chemisorption of the drug through a surface adsorption process, due to PO(3) for PO(4) exchange, that is well described by Freundlich equations. At concentrations >0.05 mol l(-1), crystalline needles of a Zoledronate complex form onto the CDAs surface. The ability of such materials to release Zoledronate, resulting in the inhibition of osteoclastic activity, was shown using a specific in vitro bone resorption model.


Subject(s)
Bone Resorption/prevention & control , Calcium Phosphates/chemistry , Diphosphonates/administration & dosage , Diphosphonates/chemistry , Drug Carriers/chemistry , Drug Implants/administration & dosage , Drug Implants/chemistry , Imidazoles/administration & dosage , Imidazoles/chemistry , Animals , Biocompatible Materials/chemistry , Bone Resorption/pathology , Cells, Cultured , Materials Testing , Osteoblasts/drug effects , Osteoblasts/pathology , Rabbits , Surface Properties , Zoledronic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...